MID-PREGNANCY CORTICOTROPIN-RELEASING HORMONE LEVELS IN ASSOCIATION WITH POSTPARTUM DEPRESSIVE SYMPTOMS

Depression and Anxiety

Volumn 33, Issue 11, 2016, Pages 1023-1030

  Iliadis, Stavros I ^a   Sylvén, Sara ^a   Hellgren, Charlotte ^a   Olivier, Jocelien D ^a,b   Schijven, Dick ^a   Comasco, Erika ^a,c   Chrousos, George P ^d   Sundström Poromaa, Inger ^a   Skalkidou, Alkistis ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

corticotropin releasing hormone; EPDS; HPA axis; peripartum depression; postpartum depression; pregnancy

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN RELEASING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DEMOGRAPHY; EDINBURGH POSTNATAL DEPRESSION SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL DEPRESSION; SMALL FOR DATE INFANT;

EID: 84971219356     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22529     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Allolio B, Hoffmann J, Linton EA, Winkelmann W, Kusche M, Schulte HM. Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) 1990;33:279–289.
3. Jung C, Ho JT, Torpy DJ, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab 2011;96:1533–1540.
4. Glynn LM, Davis EP, Sandman CA. New insights into the role of perinatal hpa-axis dysregulation in postpartum depression. Neuropeptides 2013;47:363–370.
5. Linton EA, Perkins AV, Woods RJ, et al. Corticotropin releasing hormone-binding protein (crh-bp): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab 1993;76:260–262.
6. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998;129:229–240.
7. Robinson BG, Emanuel RL, Frim DM, Majzoub JA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA 1988;85:5244–5248.
8. Jones SA, Brooks AN, Challis JR. Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab 1989;68:825–830.
9. Cheng YH, Nicholson RC, King B, et al. Glucocorticoid stimulation of corticotropin-releasing hormone gene expression requires a cyclic adenosine 3′,5′ –monophosphate regulatory element in human primary placental cytotrophoblast cells. J Clin Endocrinol Metab 2000;85:1937–1945.
10. McLean M, Bisits A, Davies J, et al. A placental clock controlling the length of human pregnancy. Nat Med 1995;1:460–463.
11. Magiakou MA, Mastorakos G, Rabin D, et al. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 1996;81:1912–1917.
12. Hannerfors AK, Hellgren C, Schijven D, et al. Treatment with serotonin reuptake inhibitors during pregnancy is associated with elevated corticotropin-releasing hormone levels. Psychoneuroendocrinology 2015;58:104–113.
13. Glynn LM, Sandman CA. Evaluation of the association between placental corticotrophin-releasing hormone and postpartum depressive symptoms. Psychosom Med 2014;76:355–362.
14. Hahn-Holbrook J, Schetter CD, Arora C, Hobel CJ. Placental corticotropin-releasing hormone mediates the association between prenatal social support and postpartum depression. Clin Psychol Sci 2013;1:253–264.
15. Yim IS, Glynn LM, Dunkel-Schetter C, et al. Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy. Arch Gen Psychiatry 2009;66:162–169.
16. Meltzer-Brody S, Stuebe A, Dole N, et al. Elevated corticotropin releasing hormone (crh) during pregnancy and risk of postpartum depression (ppd). J Clin Endocrinol Metab 2011;96:E40–E47.
17. Rich-Edwards JW, Mohllajee AP, Kleinman K, et al. Elevated midpregnancy corticotropin-releasing hormone is associated with prenatal, but not postpartum, maternal depression. J Clin Endocrinol Metab 2008;93:1946–1951.
18. O'Keane V, Lightman S, Marsh M, et al. Increased pituitary-adrenal activation and shortened gestation in a sample of depressed pregnant women: a pilot study. J Affect Disord 2011;130:300–305.
19. Kammerer M, Taylor A, Glover V. The HPA axis and perinatal depression: a hypothesis. Arch Womens Ment Health 2006;9:187–196.
20. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry 2002;7:254–275.
21. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992;267:1244–1252.
22. Iliadis SI, Comasco E, Sylven S, et al. Prenatal and postpartum evening salivary cortisol levels in association with peripartum depressive symptoms. PLoS One 2015;10:e0135471.
23. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10–item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782–786.
24. Warren WB, Goland RS, Wardlaw SL, et al. Elevated maternal plasma corticotropin releasing hormone levels in twin gestation. J Perinat Med 1990;18:39–44.
25. NICE Guidelines (CG 192). Antenatal and postnatal mental health: clinical management and service guidance. 2014. Available at: https://www.nice.org.uk/guidance/cg192.
26. Wickberg B, Hwang CP. The Edinburgh Postnatal Depression Scale: validation on a Swedish community sample. Acta Psychiatr Scand 1996;94:181–184.
27. Statens Beredning för Medicinsk Utvärdering (SBU). Diagnostik och uppföljning av förstämningssyndrom. En systematisk litteraturöversikt. 2012. Available at: http://www.sbu.se/forstamningssyndrom.
28. Murray L, Carothers AD. The validation of the edinburgh post-natal depression scale on a community sample. Br J Psychiatry 1990;157:288–290.
29. Rosengren A, Orth-Gomer K, Wedel H, Wilhelmsen L. Stressful life events, social support, and mortality in men born in 1933. BMJ 1993;307:1102–1105.
30. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125–137.
31. Stirrat LI, O'Reilly JR, Riley SC, et al. Altered maternal hypothalamic-pituitary-adrenal axis activity in obese pregnancy is associated with macrosomia and prolonged pregnancy. Pregnancy Hypertens 2014;4:238.
32. Marsal K, Persson PH, Larsen T, et al. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843–848.
33. Petraglia F, Imperatore A, Challis JR. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 2010;31:783–816.
34. Wadhwa PD, Garite TJ, Porto M, et al. Placental corticotropin-releasing hormone (crh), spontaneous preterm birth, and fetal growth restriction: a prospective investigation. Am J Obstet Gynecol 2004;191:1063–1069.
35. Murphy-Eberenz K, Zandi PP, March D, et al. Is perinatal depression familial? J Affect Disord 2006;90:49–55.
36. Latendresse G, Ruiz RJ. Maternal coping style and perceived adequacy of income predict crh levels at 14–20 weeks of gestation. Biol Res Nurs 2010;12:125–136.
37. Latendresse G, Ruiz RJ. Bioassay research methodology: measuring CRH in pregnancy. Biol Res Nurs 2008;10:54–62.
38. Stratakis CA, Chrousos GP. Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci 1995;771:1–18.